HemaSphere (Aug 2023)
P539: A PHASE 1 STUDY OF HMPL-306, A DUAL INHIBITOR OF MUTANT ISOCITRATE DEHYDROGENASE (IDH) 1 AND 2, IN PTS WITH RELAPSED/REFRACTORY MYELOID HEMATOLOGICAL MALIGNANCIES HARBORING IDH1 AND/OR 2 MUTATIONS
- Lijuan Hu,
- Wei-LI Zhao,
- Wen Wu,
- Xudong Wei,
- Ruihua MI,
- Yu Hu,
- Qiubai LI,
- Wenjuan He,
- Juan LI,
- Yugang Dong,
- Hehua Wang,
- Xuhan Zhang,
- Yu Zhang,
- Zhongyuan Xu,
- Hui Liu,
- Zhen Cai,
- Jie Sun,
- Yajing Xu,
- Zhiping Jiang,
- Cheng Zhang,
- Guo Chen,
- Tiejun Gong,
- Qinghua Tang,
- Hongmei Jing,
- Lan MA,
- Sujun Gao,
- Qiqi Liu,
- Zeyu Zhong,
- Yongxin Ren,
- Jian Chen,
- Songhua Fan,
- Michael Shi,
- Weiguo Su,
- Xiaojun Huang
Affiliations
- Lijuan Hu
- 1 Peking University People’s Hospital, Beijing, China
- Wei-LI Zhao
- 2 Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Wen Wu
- 2 Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Xudong Wei
- 3 Henan Cancer Hospital, Zhengzhou, China
- Ruihua MI
- 3 Henan Cancer Hospital, Zhengzhou, China
- Yu Hu
- 4 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- Qiubai LI
- 4 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- Wenjuan He
- 4 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- Juan LI
- 5 The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
- Yugang Dong
- 5 The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
- Hehua Wang
- 5 The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
- Xuhan Zhang
- 6 The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
- Yu Zhang
- 7 Southern Medical University Nanfang Hospital, Guangzhou, China
- Zhongyuan Xu
- 7 Southern Medical University Nanfang Hospital, Guangzhou, China
- Hui Liu
- 7 Southern Medical University Nanfang Hospital, Guangzhou, China
- Zhen Cai
- 8 The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
- Jie Sun
- 8 The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
- Yajing Xu
- 9 Xiangya Hospital Central South University, Changsha, China
- Zhiping Jiang
- 9 Xiangya Hospital Central South University, Changsha, China
- Cheng Zhang
- 10 The Second Affiliated Hospital of Army Medical University of PLA, Chongqing, China
- Guo Chen
- 10 The Second Affiliated Hospital of Army Medical University of PLA, Chongqing, China
- Tiejun Gong
- 11 Harbin First Hospital Hematological Cancer Research Center, Harbin, China
- Qinghua Tang
- 11 Harbin First Hospital Hematological Cancer Research Center, Harbin, China
- Hongmei Jing
- 12 Peking University Third Hospital, Beijing, China
- Lan MA
- 12 Peking University Third Hospital, Beijing, China
- Sujun Gao
- 13 The First Hospital of Jilin University, Changchun, China
- Qiqi Liu
- 14 HUTCHMED Limited, Shanghai, China
- Zeyu Zhong
- 14 HUTCHMED Limited, Shanghai, China
- Yongxin Ren
- 14 HUTCHMED Limited, Shanghai, China
- Jian Chen
- 14 HUTCHMED Limited, Shanghai, China
- Songhua Fan
- 14 HUTCHMED Limited, Shanghai, China
- Michael Shi
- 14 HUTCHMED Limited, Shanghai, China
- Weiguo Su
- 14 HUTCHMED Limited, Shanghai, China
- Xiaojun Huang
- 1 Peking University People’s Hospital, Beijing, China
- DOI
- https://doi.org/10.1097/01.HS9.0000969064.86312.d3
- Journal volume & issue
-
Vol. 7
p. e86312d3
Abstract
No abstracts available.
